Obesity and risk of morbidity Obesity is becoming an increasingly impo
rtant factor in the pathogenesis of hypertension, dyslipidemia and dia
betes, which together with hyperinsulinemia comprise the deadly quarte
t of the insulin resistance syndrome. Obesity in the absence of these
other factors is only a minor risk factor, but most obesity is accompa
nied by one or more of these, worsening the prognosis, The presence of
obesity complicates the management of hypertension, probably in large
part because of the concomitant insulin resistance which adds to the
pathogenetic mechanisms and subtracts from the therapeutic efficacy of
many antihypertensive regimens. Unfortunately, some of the agents use
d to reduce obesity may further aggravate the problem through their st
imulation of sympathetic nervous activity. Nonetheless, in the treatme
nt of hypertension in most obese patients who have relatively little e
xcess risk, attempts to reduce body weight should be attempted first,
through sensible dietary restrictions, increased aerobic exercise and
judicious use of non-hypertensinogenic appetite suppressants. Thereby,
additional motivation to lose weight: may be provided by the potentia
l of escaping or at least delaying antihypertensive drug therapy. Trea
tment of higher-risk obese individuals Those obese hypertensive indivi
duals at greater risk should be immediately started on antihypertensiv
e drug therapy along with attempts to reduce the obesity. The choice o
f initial and subsequent therapy should take the patient's individual
needs into account. For those with dyslipidemia or diabetes, diuretics
and P-blockers should be avoided unless there are specific indication
s for their use (e.g. reactive sodium retention or postmyocardial infa
rction). In such patients, an alpha-blocker, an angiotensin converting
enzyme inhibitor or a calcium antagonist may be more appropriate. If
the first drug is not sufficient, combination therapy should be consid
ered. A diuretic may be needed to overcome reactive sodium retention.
Because most obese hypertensive individuals will not be able to lose m
uch weight, effective antihypertensive drug therapy will usually be in
dicated. (C) 1998 Rapid Science Ltd.